APOE and triple-A syndrome: On contrary to previous studies showing that DFO inhibits inflammation and atherosclerosis in ApoE−/− mice and cholesterol-fed rabbits19, the current study demonstrated that DFO potentiated AngII-induced AAA in hyperlipidemic mice through the accumulation of HIF-1α.